Neogen Chemicals
- Market cap
- ₹ 6,514 Cr.
- P/E
- 191.8x
- P/B
- 7.24x
- 52-week range
- 966.7 – 2,785
- ROE
- 4%
- ROCE
- 6%
- Dividend yield
- 0%
- Debt / equity
- 1.71
- Sector
- Chemicals & Petrochemicals
- Industry
- Specialty Chemicals
- Listed on
- NSE, BSE
About
Neogen Chemicals Limited is an India-based company, which is engaged in the business of manufacturing of specialty chemicals. It is also engaged in manufacturing bromine compounds, lithium-based chemical compounds, advanced intermediates, and custom synthesis and contract manufacturing. Its product category includes organic chemicals, inorganic chemicals, grignard reagents, advance intermediates, and chemistries. Its organic chemicals include organo lithium compounds, specialty chloro compounds, and organo bromine compounds. Its inorganic chemicals include lithium salts. Its advance intermediates include valine methyl ester, 4-bromobutyl acetate, and others. It focuses on producing a wide range of specialty chemicals, including organic and inorganic chemicals. These chemicals are utilized in various industries, such as pharmaceuticals, agrochemicals, engineering, electronics, polymers, water treatment, construction, aroma chemicals, flavors and fragrances, and specialty polymers.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Specialty Chemicals: 130 companies →Neogen Chemicals against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)191.8 against a typical 25.8: pricier than most peers (1st = cheapest).123rd of 129
- Sales growth+33.7% against a typical +25.9% from a year earlier.42nd of 112
- Profit growth+70% against a typical +42.4% from a year earlier.40th of 102
- Share price, 3 months+9.8% against a typical −5.8%.28th of 118
- Size₹ 6,513.8 Cr. market value against a typical ₹ 359.6 Cr. (1st = largest).18th of 126
Credit ratings
Every rating action on file, newest first, including reaffirmations. Open a row for the agency's reasoning. All credit rating updates
Look closer
Rated A- by CRISIL- CRISIL lowered its rating on 17 Jul 2026.
| Agency | Current rating | Outlook | As of |
|---|---|---|---|
| CRISIL | Crisil A- | Stable | 25 Sep 2026 |
| Rating | Details | |||||
|---|---|---|---|---|---|---|
| 25 Sep 2026 | ▲ Outlook raised | Crisil A- Outlook Negative → Stable | — | CRISIL | ₹ 880 Cr. | |
| 17 Jul 2026 | ▼ Downgrade | Crisil A- | — | CRISIL | ₹ 880 Cr. |
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 24 Jul 2026 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended Jun 30, 2026 and Fund Raising |
| 16 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2026 and dividend |
| 7 Mar 2026 | Fund Raising/Other business matters | To consider, evaluate and approve the proposal for raising of funds by way of issue of equity shares in one or more tranche by way of a Preferential Issue, and other connected matters. |
| 11 Feb 2026 | Financial Results/Fund Raising | To consider and approve the financial results for the period ended December 31, 2025 and Fund Raising |
| 8 Nov 2025 | Financial Results | To consider and approve the financial results for the period ended September 30, 2025 |
| 2 Aug 2025 | Financial Results | To consider and approve the financial results (standalone and consolidated) for the quarter ended June 30, 2025. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 162 | 164 | 200 | 180 | 193 | 201 | 203 | 187 | 209 | 220 | 247 | 250 |
| Expenses | 136 | 144 | 164 | 149 | 159 | 167 | 166 | 155 | 179 | 188 | 203 | 202 |
| Operating Profit | 26 | 20 | 36 | 31 | 35 | 35 | 36 | 32 | 30 | 32 | 44 | 48 |
| OPM % | 16% | 12% | 18% | 17% | 18% | 17% | 18% | 17% | 14% | 14% | 18% | 19% |
| Other Income | 2 | 2 | 2 | 2 | 1 | 1 | −13 | 1 | 2 | 2 | 1 | 4 |
| Interest | 11 | 11 | 10 | 10 | 13 | 13 | 12 | 13 | 19 | 22 | 21 | 21 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 8 | 8 |
| Profit before tax | 11 | 6 | 22 | 16 | 15 | 15 | 4 | 14 | 5 | 6 | 16 | 23 |
| Tax % | 28% | 81% | 25% | 27% | 29% | 34% | 35% | 28% | 35% | 36% | 28% | 26% |
| Net Profit | 8 | 1 | 17 | 11 | 11 | 10 | 2 | 10 | 3 | 4 | 11 | 17 |
| EPS in Rs | 3.18 | 0.4 | 6.42 | 4.35 | 4.15 | 3.79 | 0.91 | 3.89 | 1.28 | 1.4 | 4.32 | 6.25 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 24%
- 5 Years
- 21%
- 3 Years
- 8%
- TTM
- 18%
- 10 Years
- 19%
- 5 Years
- −2%
- 3 Years
- −17%
- TTM
- −12%
- 10 Years
- —
- 5 Years
- 19%
- 3 Years
- 13%
- TTM
- —
- 10 Years
- 9%
- 5 Years
- 7%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Neogen Chemicals | ₹ 2,250.00 | ₹ 6,514 Cr. | 191.8x | 7.2x | 4% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 58.1x | 12.1x | 21.2% | 12.4% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 99.6x | 26.6x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 64.8x | 14.7x | 23.8% | 16.9% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 44.6x | 6.1x | 13.8% | 11.6% |
| Linde India | ₹ 5,697.00 | ₹ 48,586 Cr. | 110.5x | 14.2x | 13.6% | 21.7% |
Management
- Gopikrishnan Sarathy
- Chief Financial Officer
- Unnati Kanani
- Compliance Officer, Company Secretary
- Harin H. Kanani
- Managing Director, Executive Director
- Triplicane Commandoor Narasimhan Saikrishnan
- Executive Director
- Shyamsunder Upadhyay
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.